Mohs surgical excision of a granular cell tumor with plexiform features on the arm of a 7-year-old child.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20187892)

Published in Dermatol Surg on February 19, 2010

Authors

Sherry M Youssef1, Molly Hinshaw, B Jack Longley, Stephen Snow, Joyce M C Teng

Author Affiliations

1: Department of Dermatology, University of Wisconsin, Madison, Wisconsin, USA.

Articles by these authors

Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol (2002) 20.87

Chemically defined conditions for human iPSC derivation and culture. Nat Methods (2011) 5.84

Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol (2002) 2.95

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood (2002) 2.39

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol (2002) 2.19

MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res (2007) 2.08

Kikuchi's disease: case report and systematic review of cutaneous and histopathologic presentations. J Am Acad Dermatol (2008) 1.60

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Exp Hematol (2003) 1.55

A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol Biomarkers Prev (2006) 1.41

Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology (2005) 1.32

Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J (2005) 1.28

Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J Invest Dermatol (2010) 1.27

A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila) (2010) 1.21

Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo. J Invest Dermatol (2006) 1.21

Heck's disease: diagnosis and susceptibility. Pediatr Dermatol (2009) 1.05

Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations. Am J Dermatopathol (2013) 1.02

Hidradenomas and a hidradenocarcinoma of the scalp managed using Mohs micrographic surgery and a multidisciplinary approach: case reports and review of the literature. Dermatol Surg (2009) 1.01

Pyoderma gangrenosum of penis. J Urol (2003) 1.00

Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures. J Neurosci (2010) 0.98

MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression. PLoS One (2011) 0.93

Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am J Clin Oncol (2014) 0.90

Cutaneous adenoid cystic carcinoma with perineural invasion treated by mohs micrographic surgery-a case report with literature review. J Oncol (2010) 0.89

Epigenetic control of MAGE gene expression by the KIT tyrosine kinase. J Invest Dermatol (2007) 0.87

A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity. Cancer Prev Res (Phila) (2012) 0.84

Expression of angiopoietin-TIE system components in angiosarcoma. Mod Pathol (2013) 0.84

Transportation behaviours of older adults: an investigation into car dependency in urban Australia. Australas J Ageing (2012) 0.84

Calciphylaxis responsive to lanthanum carbonate (FOSRENOL) therapy. WMJ (2008) 0.83

Atypical cellular disorders. Hematology Am Soc Hematol Educ Program (2002) 0.83

Identification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1. Arch Biochem Biophys (2011) 0.82

Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment. Melanoma Res (2011) 0.81

(V600E)Braf::Tyr-CreERT2::K14-Kitl mice do not develop superficial spreading-like melanoma: keratinocyte Kit ligand is insufficient to "translocate" (V600E)Braf-driven melanoma to the epidermis. J Invest Dermatol (2011) 0.81

Sweet's panniculitis associated with metastatic breast cancer. J Am Acad Dermatol (2007) 0.81

Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues. Exp Dermatol (2014) 0.81

Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery. Cutis (2010) 0.80

Eccrine Porocarcinoma Treated by Mohs Micrographic Surgery: Over 6-Year Follow-up of 12 Cases and Literature Review. Dermatol Surg (2015) 0.79

Upregulation of PI3K/AKT/mTOR, FABP5 and PPARβ/δ in Human Psoriasis and Imiquimod-induced Murine Psoriasiform Dermatitis Model. Acta Derm Venereol (2016) 0.79

Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res (2014) 0.78

KIT masters mast cells in kids, too. J Invest Dermatol (2010) 0.78

Metastatic transitional cell carcinoma of the bladder presenting as genital edema. J Am Acad Dermatol (2004) 0.77

Mohs micrographic surgery for the treatment of localized cutaneous alternariosis. J Am Acad Dermatol (2013) 0.76

Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature. Dermatol Ther (2014) 0.76

A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy. Pediatr Dermatol (2011) 0.75

Psychic centrality: reflections on two psychohistoriographic cultural therapy workshops in Montreal. Transcult Psychiatry (2010) 0.75

Use of genetic tools to control tumor margins in melanoma. Arch Dermatol (2009) 0.75

Generalized bullae in an infant. Arch Dermatol (2002) 0.75

Genetic diseases associated with an increased risk of skin cancer development in childhood. Curr Opin Pediatr (2017) 0.75

Advancement in management of epidermolysis bullosa. Curr Opin Pediatr (2016) 0.75

A generalized annular eruption with occasional vesicles. Arch Dermatol (2012) 0.75

Chronic disseminated cutaneous blastomycosis in an 11-year old, with a brief review of the literature. Pediatr Dermatol (2006) 0.75

Serpiginous erythematous plaques on the feet. Arch Dermatol (2011) 0.75

Effective topical combination therapy for treatment of lichen striatus in children: a case series and review. J Drugs Dermatol (2012) 0.75

Multiple painful vaginal ulcerations. Arch Dermatol (2008) 0.75

A puzzling case of persistent purpura. Am J Med (2008) 0.75

Black spots in the returning traveler. Dermatol Online J (2013) 0.75

Correspondence: The association between morphea profunda and monoclonal gammopathy: A case series. Dermatol Online J (2016) 0.75

Thrombotic lymphocytic vasculitic reaction to intravenous immunoglobulin. J Am Acad Dermatol (2006) 0.75

Adult-onset unilateral segmental vascular patches--quiz case. Unilateral nevoid telangiectasia. Arch Dermatol (2010) 0.75

A 38-year-old woman with eyelid discoloration. Heliotrope-like manifestation of adult-onset Still disease (AOSD). Arch Dermatol (2012) 0.75

TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold. Dermatol Online J (2017) 0.75

An erythematous plaque filled with open and closed comedones. Arch Dermatol (2010) 0.75

Coral contact dermatitis. Dermatol Online J (2015) 0.75